A Comparative study of Duralabhadileha and Vasavaleha in the management of Tamaka Shwasa (Childhood Asthma) in the age group of 5 to 12 years.

â??A standard controlled clinical trial of Duralabhadileha and Vasavaleha in the management of Tamaka Shwasa Avegavastha (Childhood Asthma)

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/09/021012

Enrollment

Registered

2019-09-02

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J069- Acute upper respiratory infection,unspecified

Interventions

Intervention1: Duralabhadileha: Duralabhadileha is prepared by avaleha kalpana will be given orally to the children in between 5 to 12 years of age. the dose is calculated by clarks rule which is 600

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subject having age group 5 to 12 years will be selected irrespective of gender with following criteria. 2. Classical symptoms of TAMAKA Shawasa as per CharakSamita(Chikitsa 17/60)like kasa(cough) ,urahghurghrta(wheezing) , shwaskrichhata(dyspnea) etc of mild to moderate degree.5 3. Patient suffered with at least2 attack of dyspnoea will be selected. 4. Patient already on Inhaled corticosteroid (ICS) for acute attack will be taken after discontinuation of treatment.

Exclusion criteria

Exclusion criteria: 1. Severe case of Asthma like status asthmatics 2. Known case of acute respiratory infection like pneumonia, Bronchitis, whooping cough. 3. Known case of congenital heart disease. 4. Known case of chronic infections like Tuberculosis.

Design outcomes

Primary

Measure	Time frame
To compare the efficacy of Duralabhadileha and Vasavaleha in the management of Tamaka Shwasa Avegavastha.Timepoint: 30 days with follow up on 7th 15th 21st 30th day	—

Secondary

Measure	Time frame
To observe the adverse effect of Duralabhadileha and Vasavaleha in the management of TAMAKA Shwasa Avegavastha, if any. Timepoint: 30 DAYS	—

Countries

India

Contacts

Public ContactDr Vidya Khobragade

PDEAS COLLEGE OF AYURVEDA AND RESEARCH CENTER

drsudha2010@gmail.com9975404439

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026